The 16th Biennial Meeting will start on August 10-13, 2023. It will be a hybrid meeting with virtual and in-person participation. The Association for Ocular Pharmacology and Therapeutics (AOPT) Biennial Scientific Meeting is an international conference dedicated to discussing exciting discoveries related to treating ocular diseases. Meeting participants include clinicians, eye care professionals, academics, industry scientists, and entrepreneurs.
The Association for Ocular Pharmacology and Therapeutics is a global not-for-profit 501c3 organization for scientists and individuals from all disciplines related to ocular pharmacology and its therapeutic applications. AOPT has a diverse, multi-national membership composed of preclinical and clinical scientists, students, healthcare professionals and industry partners. Members are from academic institutions, pharma and biotech industries, device companies, clinics and private practice.
To achieve its mission, the society organizes biennial conferences and provides editorial leadership for the peer-reviewed Journal of Ocular Pharmacology and Therapeutics (JOPT).
The Board of Trustees strives to achieve global growth, reach society, and make the Board composition and committees representative of its membership.
The mission of AOPT is to serve as a global forum and network for the publication, dissemination and exchange of information and knowledge on treatments of eye diseases, from basic and clinical ocular pharmacology and therapeutics to related disciplines such as pharmacokinetics and dynamics, metabolism, translational research, safety, drug delivery, and pharmaceutics. To promote the advancement of research and scientific progress in these fields. To assist researchers and eye-care professionals in furthering their understanding of the treatment of ocular disorders.